NYSE:COV (COV) (COV) Stock Price, News & Analysis → Top Project Outperforms BTC in 2023… (From Crypto 101 Media) (Ad) Free COV Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume3.88 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (COV) alerts: Email Address Ad Crypto 101 MediaTop Project Outperforms BTC in 2023…According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.Just click here for instant access to the #1 Coin for 2024. About (COV) Stock (NYSE:COV)Covidien Public Limited Company is a healthcare products company. The Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. The Company’s brands include Kendall, Nellcor, Puritan Bennett and Valleylab, among others. It has a presence in more than 70 countries, with products sold in over 150 countries. The Company’s segments include Medical Devices and United States Medical Supplies. Medical Devices includes marketing of advanced and general surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. United States Medical Supplies includes products, such as nursing care, medical surgical, SharpSafety and original equipment manufacturer (OEM) products. The Company’s products include Surgical Solutions, Vascular Therapies, Respiratory and Patient Care.Read More Ad Crypto 101 MediaTop Project Outperforms BTC in 2023…According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.Just click here for instant access to the #1 Coin for 2024. COV Stock News HeadlinesMarch 28, 2024 | msn.com'Post-viral malaise': Why avoiding the term 'long-COVID' doesn't change anything for those affectedMarch 28, 2024 | msn.comGovt Confirms Outbreak of Infectious Disease; Gives Prevention TipsMarch 29, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.March 28, 2024 | msn.comGet your cameras ready: 'Love the Cov' sculpture installed on Covington Riverfront CommonsMarch 27, 2024 | msn.comCardiovascular risks and COVID-19: New research confirms the benefits of vaccinationMarch 27, 2024 | msn.comResearchers employ microfluidic diffusional sizing characterize neutralizing antibody affinity to SARS-CoV-2March 26, 2024 | theglobeandmail.comClosing Bell: CI Can Banks Cov Call Income Class ETF flat on Monday (CIC)March 26, 2024 | msn.comNew roadmap to prevent pandemics centers on protecting biodiversityMarch 29, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.March 26, 2024 | msn.comCardiovascular Risks and Covid-19 - New Research Confirms the Benefits of Vaccination [analysis]March 26, 2024 | bizjournals.comFDA authorizes Waltham company’s Covid prevention drugMarch 26, 2024 | msn.comMolnupiravir influences SARS-CoV-2 evolution in immunocompromised patientsMarch 25, 2024 | msn.comSuperspreaders: Humans pass twice as many viruses to animals as we catch from themMarch 25, 2024 | msn.comCOVID-19 survivors face increased psychiatric risks, spotlight on vaccination's mental health benefitsMarch 24, 2024 | msn.comCOVID Linked to Lower IQ, Poor Memory and Other Negative Impacts on Brain HealthMarch 23, 2024 | msn.comProject PROTECTS launches to track acute respiratory infections across the United StatesMarch 23, 2024 | msn.comLong Covid ‘indistinguishable’ from other post-viral syndromesMarch 21, 2024 | msn.com"Severe" lung infection from Covid 19 can damage heart, according to new studyMarch 21, 2024 | yahoo.comMounting research shows COVID-19 leaves its mark on the brain, including significant drops in IQMarch 20, 2024 | msn.comJoint hypermobility linked to longer COVID-19 recovery timeMarch 20, 2024 | msn.comStudy finds antibiotics combat gut bacteria that contribute to the pathogenesis of COVID-19March 20, 2024 | msn.comSARS-CoV-2-associated ARDS can damage the heart without direct infectionMarch 20, 2024 | msn.comSevere lung infection during COVID-19 can cause damage to the heartMarch 19, 2024 | msn.comNanoparticles target multiple COVID variants through the twist in the spike proteinMarch 19, 2024 | msn.comSeverity of current SARS-CoV-2 variants is not linked to the number of mutationsMarch 19, 2024 | msn.comSARS-CoV-2 spike protein sensitizes nociceptors and evokes nociceptive behaviorsMarch 19, 2024 | theglobeandmail.comClosing Bell: CI Hlth Care Giant Cov Call ETF down on Friday (FHI)See More Headlines Receive COV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (COV) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/05/2014Today3/28/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryHealth Care Equipment Current SymbolNYSE:COV CUSIPG2554F11 CIK1385187 WebN/A Phone+353-1-4381700FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesGary L. Ellis (Age 61)President, Chief Executive Officer Charles J. Dockendorff (Age 63)Chief Financial Officer, Executive Vice President Bryan C. Hanson (Age 50)Group President, Covidien John H. Masterson (Age 54)Senior Vice President, General Counsel Michael P. Dunford (Age 54)Senior Vice President - Human Resources James C. Clemmer (Age 53)Senior Vice President and President - Medical Supplies Business Amy A. McBride-Wendell (Age 53)Senior Vice President - Strategy and Business Development Jacqueline F. Strayer (Age 58)Senior Vice President-Corporate Communications Michael E. Tarnoff (Age 46)Senior Vice President,Chief Medical Officer Peter L. Wehrly (Age 57)Senior Vice President, Group President - Developed Markets More Executives COV Stock Analysis - Frequently Asked Questions How were (COV)'s earnings last quarter? (COV) (NYSE:COV) announced its earnings results on Wednesday, November, 5th. The healthcare company reported $1.15 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.02 by $0.13. The healthcare company had revenue of $2.73 billion for the quarter, compared to analyst estimates of $2.69 billion. The firm's revenue was up 6.8% compared to the same quarter last year. During the same quarter last year, the business posted $0.91 EPS. What other stocks do shareholders of (COV) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (COV) investors own include Pfizer (PFE), Chevron (CVX), Intel (INTC), Johnson & Johnson (JNJ), Boeing (BA), CVS Health (CVS), EMC (EMC), Gilead Sciences (GILD) and JPMorgan Chase & Co. (JPM). This page (NYSE:COV) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (COV) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.